This paper is in the following e-collection/theme issue:

Opinion: Viewpoints, Perspectives, and Opinion papers by patients and patient advocates (not grant supported) (11) Consumer & Patient Education and Shared-Decision Making (760) Participatory Medicine & E-Patients (829)

Published on in Vol 11, No 3 (2019): Jul-Sep

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13800, first published .
Personalizing Value in Cancer Care: The Case for Incorporating Patient Preferences Into Routine Clinical Decision Making

Personalizing Value in Cancer Care: The Case for Incorporating Patient Preferences Into Routine Clinical Decision Making

Personalizing Value in Cancer Care: The Case for Incorporating Patient Preferences Into Routine Clinical Decision Making

Authors of this article:

Joshua Seidman1 Author Orcid Image ;   Domitilla Masi1 Author Orcid Image ;   Amalia Elvira Gomez-Rexrode2 Author Orcid Image
Article Authors Cited by (3) Tweetations (5) Metrics

Journals

  1. Bosserman L, Mambetsariev I, Ladbury C, Barzi A, Johnson D, Morse D, Deaville D, Smith W, Rajurkar S, Merla A, Hajjar G, Kim D, Fricke J, Trisal V, Salgia R. Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans. Journal of Clinical Medicine 2022;11(22):6738 View
  2. Commaroto S, Camacho-Rivera M, Guo Y, Hong Y, Turner K, Islam I, Rivera A, Islam J. Racial and ethnic disparities in knowledge, attitudes, and invitation to participate in clinical trials among cancer survivors in the United States: An analysis of the 2020 U.S. HINTS. Preventive Medicine Reports 2024;37:102564 View
  3. Bas T, Duarte V. Biosimilars in the Era of Artificial Intelligence—International Regulations and the Use in Oncological Treatments. Pharmaceuticals 2024;17(7):925 View